Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Glaxo Executives Reinvest Dividends

3rd Oct 2014 14:31

LONDON (Alliance News) - GlaxoSmithKline PLC Friday said a group of executives, including Chief Executive Officer Andrew Witty, acquired shares at a price of 1415.94 pence per share, as a result of the reinvestment of dividends held in the GlaxoSmithKline ShareReward Plan Thursday.

Details are as follows.

Director/Manager

 

Ordinary Shares

 

 

Sir Andrew Witty

 

36

 

Mr S Dingemans

 

10

 

Mr R G Connor

 

44

 

Mr S A Hussain

 

9

 

Mr D S Redfern

 

52

 

Ms C Thomas

 

52

 

Mr P C Thomson

 

24

 

Dr P J T Vallance

 

29

 

Ms E Walmsley

 

5

 

Mrs V A Whyte

 

34

 

 

Connected person

 

Ordinary Shares

 

Mrs K Thomson (Connected person of Mr P C Thomson)

 

 

14


The company also said the following execuives and connected persons acquired shares at a price of 1417.515 pence per Ordinary Share, as a result of the reinvestment of the dividend paid to shareholders on Thursday.

Director/Manager

 

Ordinary Shares

 

 

Sir Andrew Witty

 

4,258

 

 

Connected person

 

Ordinary Shares

 

Lady C Witty

 

(Connected person of Sir Andrew Witty)

 

2,045

 

Mr I W Whyte

 

(Connected person of Mrs V A Whyte)

 

268


The stock was trading at 1,422.50 pence, up 1.4%, Friday.

By Arvind Bhunjun; [email protected]; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,726.40
Change7.65